In this episode, we discuss... How Evan Sengbusch’s background in physics led him to his current role as President of Phoenix Production of lower energy, higher current deuteron accelerators as neutron sources The roles preserving research reactors and producing a domestic supply of Molybdenum 99 play in the nation’s medical industry New capabilities of thermal neutron imaging and fast neutron imaging The development of neutrons as an inspection tool for complex, high density materials and components How Phoenix’s partnership with SHINE could change medical radioisotope production in the US